Large-scale testing (Phase 3)Study completedNCT02476006
What this trial is testing
Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)
Who this might be right for
Hypercholesterolemia
Sanofi 998